Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study
Endocrine · 01.04.2026 · 91 (1)
DOI: 10.1007/s12020-026-04595-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 01.04.2026. Verfasst von Liyuan Kou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases,…. Hauptthemen laut MEDLINE: Hypercalcemia. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Peking Union Medical College Hospital Talent Cultivation Program Category D, National Natural Science Foundation of China, Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS).
Abstract (Originalsprache)
PURPOSE: To characterize the clinical and genetic features of Chinese FHH type 1 (FHH1) patients and evaluate biochemical discriminators between FHH1 and sporadic primary hyperparathyroidism (s-PHPT). METHODS: This retrospective study included 11 genetically confirmed FHH1 and 55 s-PHPT patients. Their clinical, biochemical, and imaging data were compared. Genetic testing was conducted via targeted next-generation or whole-exome sequencing. The key discriminators were assessed by receiver operating characteristic (ROC) analysis. RESULTS: Among the 11 FHH1 patients, 63.6% were females and 63.6% had a family history. Incidentally detected hypercalcemia was the most common cause (72.7%). Compared with s-PHPT, FHH1 were younger at diagnosis [38.1 ± 17.4 years vs. 53.6 ± 14.0, P = 0.002], had lower parathyroid hormone level [41.80 (28.89, 124.00) pg/mL vs. 233.90 (136.6, 521.6) pg/mL, P C, c.488 C >T, c.1042del, c.2386 A >G). ROC analysis indicated that 24hUCa < 3.71 mmol/24 h optimally distinguished FHH1 from s-PHPT. CONCLUSION: The relatively large single-center Chinese FHH1 cohort presented younger with similar serum calcium, milder PTH elevation, relatively normal BTMs, and less target-organ involvement than s-PHPT. A new cut-off value of 24hUCa may serve as a practical pre-genetic screening tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sci…
- Key laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing, Beijing, 100730, Chin…
ORCID-Profile: Liyuan Kou, An Song, Min Nie, Yue Jiang, Yingyu Chen, Yiyang Gao, Yan Jiang, Mei Li, Weibo Xia, Ou Wang, Xiaoping Xing
Förderung
- Peking Union Medical College Hospital Talent Cultivation Program Category D
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS)
Zitieren
APA
Kou, L., Song, A., Nie, M., Jiang, Y., Chen, Y., Gao, Y., Jiang, Y., Li, M., Xia, W., Wang, O., & Xing, X. (2026). Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04595-7
Vancouver
Kou L, Song A, Nie M, Jiang Y, Chen Y, Gao Y, et al. Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study. Endocrine. 2026;91(1). doi:10.1007/s12020-026-04595-7
BibTeX
@article{Kou2026,
author = {Kou, Liyuan and Song, An and Nie, Min and Jiang, Yue and Chen, Yingyu and Gao, Yiyang and Jiang, Yan and Li, Mei and Xia, Weibo and Wang, Ou and Xing, Xiaoping},
title = {Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study},
journal = {Endocrine},
year = {2026},
volume = {91},
number = {1},
doi = {10.1007/s12020-026-04595-7}
}
EUVIMED